Immunotherapy and Transarterial Radioembolization Combination Treatment for Advanced Hepatocellular Carcinoma.

Yee Hui YeoJeff LiangMarie LauzonMichael LuuMazen NoureddinWalid AyoubAlexander KuoKamya SankarJun GongAndrew HendifarArsen OsipovMarc L FriedmanH Gabriel LipshutzJonathan SteinbergerKambiz KosariNicholas NissenGhassan K Abou-AlfaAmit G SingalJu Dong Yang

Published in: The American journal of gastroenterology (2023)

The combination of TARE and immunotherapy was associated with improved survival compared to immunotherapy alone in patients with advanced stage HCC. Our findings underly the importance of large clinical trials evaluating combination therapy in these patients.

Keyphrases

combination therapy
clinical trial
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
randomized controlled trial
phase ii
open label
free survival
phase iii